NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.VANCOUVER, British Columbia, Sept. 23, 2024 (GLOBE ...
BKV Corporation (“BKV”) today announced that it has launched the initial public offering of 15,000,000 shares of its common stock. The underwriters will have a 30-day option to purchase an additional ...
Guardian Pharmacy Services, Inc. (“Guardian”) today announced the launch of its underwritten initial public offering of 6,750,000 shares of its Class A common stock pursuant to a registration ...
How does Nasdaq measure compliance with the initial listing price requirement when a company lists pursuant to an initial ...
The Offering was conducted on a firm commitment basis. R.F. Lafferty & Co., Inc., acted as the sole underwriter (the “Underwriter”) for the Offering. Pryor Cashman LLP acted as U.S. counsel to the ...
DENVER, September 16, 2024--(BUSINESS WIRE)--BKV Corporation ("BKV") today announced that it has launched the initial public offering of ... growth-driven energy company focused on creating ...
BKV Corporation (“BKV”) today announced that it has launched the initial public offering of 15,000,000 ... growth-driven energy company focused on creating value for its stockholders.
New York, NY, Sept. 17, 2024 (GLOBE NEWSWIRE) -- YHN Acquisition I Limited (the “Company”) announced today that it priced its initial public offering of 6,000,000 units at $10.00 per unit.
WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the ...
Mr. Narongsak further stated this is the first time for GC to offer subordinated hybrid debentures, and the first time for ...
Ltd. ("Autozi" or the "Company") (NasdaqGM: AZI), one of the leading and fast-growing lifecycle automotive service providers in China, today announced the pricing of its initial public offering ...
a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its ...